Eliot Forster is PRESIDENT AND CEO of F-star Therapeutics, Inc.. Currently has a direct ownership of 0 shares of FSTX, which is worth approximately $0. The most recent transaction as insider was on Mar 08, 2023, when has been sold 347,578 shares (Common Stock) at a price of $7.12 per share, resulting in proceeds of $2,474,755. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Eliot Forster Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$2,474,755 $7.12 p/Share
347,578 Reduced 82.45%
73,959 Common Stock
Mar 08 2023
SELL
Sale (or disposition) back to the issuer
$526,588 $7.12 p/Share
73,959 Reduced 100.0%
0 Common Stock
Jul 29 2022
BUY
Exercise of conversion of derivative security
$28,707 $0.11 p/Share
260,977 Added 38.24%
421,537 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
142,000 Added 46.93%
160,560 Common Stock
Nov 20 2020
BUY
Grant, award, or other acquisition
-
18,560 Added 50.0%
18,560 Common Stock

Also insider at

PLX
Protalix BioTherapeutics, Inc. Healthcare
EF

Eliot Forster

PRESIDENT AND CEO
Cambridge, X0

Track Institutional and Insider Activities on FSTX

Follow F-star Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FSTX shares.

Notify only if

Insider Trading

Get notified when an F Star Therapeutics, Inc. insider buys or sells FSTX shares.

Notify only if

News

Receive news related to F-star Therapeutics, Inc.

Track Activities on FSTX